QHSLab, Inc. Files 8-K with Regulatory Disclosures
Ticker: USAQ · Form: 8-K · Filed: Feb 11, 2025 · CIK: 856984
Sentiment: neutral
Topics: regulatory-disclosure, exhibits, company-history
TL;DR
QHSLab (QHS) filed an 8-K on Feb 11, 2025, for Reg FD disclosure & exhibits. Nothing major revealed yet.
AI Summary
On February 11, 2025, QHSLab, Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure and includes financial statements and exhibits. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is incorporated in Nevada and operates in the Surgical & Medical Instruments & Apparatus industry.
Why It Matters
This 8-K filing indicates that QHSLab, Inc. is making important disclosures to the public, which could impact investor understanding of the company's current status and regulatory compliance.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for regulatory disclosure and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- QHSLab, Inc. (company) — Registrant
- February 11, 2025 (date) — Date of earliest event reported
- USA EQUITIES CORP. (company) — Former company name
- AMERICAN BIOGENETIC SCIENCES INC (company) — Former company name
- Nevada (jurisdiction) — State of Incorporation
- 3841 (sic_code) — Standard Industrial Classification
FAQ
What specific information is being disclosed under Regulation FD?
The filing states it is a Regulation FD Disclosure, but the specific details of the disclosure are not provided within the provided text, only that it is being reported.
What are the key exhibits included with this 8-K filing?
The filing indicates that it includes 'Financial Statements and Exhibits', but the specific list or content of these exhibits is not detailed in the provided text.
When was QHSLab, Inc. previously known by other names?
QHSLab, Inc. was formerly known as USA EQUITY CORP. (name change date 20151116) and AMERICAN BIOGENETIC SCIENCES INC (name change date 19940426).
What is the primary business of QHSLab, Inc. according to its SIC code?
QHSLab, Inc. is classified under Standard Industrial Classification code 3841, which corresponds to 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS'.
Where is QHSLab, Inc. headquartered?
QHSLab, Inc.'s business address is located at 901 Northpoint Parkway, Suite 302, West Palm Beach, FL 33407.
Filing Stats: 665 words · 3 min read · ~2 pages · Grade level 11 · Accepted 2025-02-11 09:00:11
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value USAQ N/A Item 7.01 Regu
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 20KB
- ex99-1_001.jpg (GRAPHIC) — 21KB
- 0001493152-25-005807.txt ( ) — 260KB
- usaq-20250211.xsd (EX-101.SCH) — 3KB
- usaq-20250211_lab.xml (EX-101.LAB) — 33KB
- usaq-20250211_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: February 11, 2025 QHSLab, Inc. /s/ Troy Grogan Name: Troy Grogan Title: CEO and Chairman